<DOC>
	<DOCNO>NCT00446810</DOCNO>
	<brief_summary>An AGE-rich diet induce 2-6 week persistent increase mediator link vascular dysfunction ( e.g . TNFÎ± , VCAM-1 ) people type 2 diabetes mellitus ( T2DM ) . Benfotiamine ( BT ) , liposoluble derivative vitamin B1 , block several pathway common hyperglycaemia- AGE-induced endothelial dysfunction . We show advanced glycation end product ( AGE ) regular mixed meal acutely induce vascular dysfunction T2DM effect prevent three day pretreatment BT . The hypothesis study chronical treatment benfotiamine ( 900 mg/day 6 week ) people type 2 diabetes mellitus : 1. prevents postprandial impairment endothelial function high-AGE meal . 2 . Improves fast endothelial function . 3 . Improves parameter autonomic function fast postprandial state . 4 . Improves insulin sensitivity prevents postprandial increase insulin resistance .</brief_summary>
	<brief_title>Chronic Treatment With Benfotiamine Restores Endothelial Function People With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>People type 2 diabetes mellitus ( T2DM ) two fivefold increase cardiovascular mortality compare non-diabetic control . Endothelial dysfunction ( ED ) early messenger atherosclerosis responsible increase vascular permeability , platelet aggregation adhesion , leucocyte adhesion smooth muscle cell proliferation favour vasoconstrictive pro-inflammatory state . Postprandial ED occur patient CV disease diabetes , even healthy subject . Distinctive cumulative effect hyperglycemia hypertriglyceridemia postprandial ED demonstrate . Since postprandial dysmetabolism link CV disease , postprandial ED propose mechanism connect . Considering postprandial state cover daytime , intervention target reduction postprandial ED might play decisive role atherosclerosis prevention . For treatment postprandial ED several therapeutical approach suggest , treatment folic acid , tetrahydrobiopterin , vitamins C E , statins etc . These approach aim reduce postprandial oxidative stress ( vitamin C E , statins partly folic acid ) , postprandial hyperglycemia ( insulin ) , postprandial hypertriglyceridemia ( statin ) direct effect endothelial NO production ( folic acid , insulin tetrahydrobiopterin ) . Recent data suggests advance glycation endproducts ( AGE ) might also play role development ED , lead long-term complication diabetes accelerate age . AGEs heterogeneous group moiety , one representative carboxymethyllysine ( CML ) . Diet major source exogenous AGEs food AGE content highly dependent food nutrient composition , well temperature , method duration heat application cooking . About 10 % ingested AGEs rapidly absorb partly retain body , exert different pathological effect include bind activation receptor AGE ( RAGE ) . AGE precursor methylglyoxal ( MG ) also activate RAGE . Endogenous MG synthesis increase parallel hyperglycemia vivo . Postprandially , absorb endogenously generate AGEs MG act synergistically decrease vascular function direct NO scavenging increase oxidative stress . Part effect counteract benfotiamine ( BT ) , liposoluble vitamin B1 derivative much high bioavailability thiamine . BT , commonly use treatment diabetic neuropathy , transketolase activator direct glucose substrate pentose phosphate pathway . Thus , block several hyperglycemia-induced pathway , one endogenous AGE dicarbonyls formation . We recently show three day pretreatment benfotiamine prevent postprandial ED T2DM ( Stirban et al , Diabetes Care , 2006 ) . This study aim investigate effect chronical treatment benfotiamine ( 900 mg/day 6 week ) parameter endothelial function autonomic neuropathy fast postprandial state people T2DM . We therefore investigate 30 people type 2 diabetes mellitus randomize , cross-over , double blind , placebo-controlled design . Pre- postprandial endothelial dysfunction ( flow mediate dilatation -ultrasound- reactive hyperemia -laser-doppler- ) investigate chronical treatment benfotiamine . Investigations perform fast state well 2,4 6 hour postprandially .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Benphothiamine</mesh_term>
	<criteria>People type 2 diabetes mellitus Age : 3070 year History myocardial infarction , stroke within previous 6 month Heart failure NYHA III Malignant disease Severe diabetes complication Severe hypo hypertension Chronic alcohol abuse Renal failure ( creatinine &gt; 2mg/dl )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>diabetes</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>benfotiamine</keyword>
	<keyword>postprandial</keyword>
	<keyword>autonomic neuropathy</keyword>
	<keyword>advanced glycation end product</keyword>
</DOC>